Prodrug Comprising a Drug Linker Conjugate

wherein the dashed line indicates the attachment to the amine of the biologically active moiety and wherein R1, R1a, R2, R2a, R3, R3a, X, X1, X2, X3 have the meaning as indicated in the description and the claims and wherein L1 is substituted with one to four groups L2-Z and optionally further subst...

Full description

Saved in:
Bibliographic Details
Main Authors Kaden Silvia, Wegge Thomas, Cleeman Felix, Hersel Ulrich, Rau Harald
Format Patent
LanguageEnglish
Published 13.04.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:wherein the dashed line indicates the attachment to the amine of the biologically active moiety and wherein R1, R1a, R2, R2a, R3, R3a, X, X1, X2, X3 have the meaning as indicated in the description and the claims and wherein L1 is substituted with one to four groups L2-Z and optionally further substituted, provided that the hydrogen marked with the asterisk in formula (I) is not replaced by a substituent; wherein L2 is a single chemical bond or a spacer; and Z is a carrier group. The invention also relates to A-L, wherein A is a leaving group, pharmaceutical composition comprising said prodrugs and their use as medicaments.
Bibliography:Application Number: US201615385179